Yenos Analytical Launches Multi-Cancer Early Detection Urine Test
The direct-to-consumer laboratory-developed test detects six cancer types with 97% sensitivity and specificity using microRNA biomarkers, according to the company.
The direct-to-consumer laboratory-developed test detects six cancer types with 97% sensitivity and specificity using microRNA biomarkers, according to the company.
The new interim CEO currently serves as senior vice president and chief operating officer at the organization.
The College of American Pathologists will begin searching for a permanent replacement while naming an interim CEO.
The merger brings together Labguru’s data management and ELN technologies with Mosaic’s automation and orchestration capabilities.
Read MoreWhile functional medicine has long existed on the fringes of healthcare, Adam El-Hosseiny, COO of Access Medical Labs, believes it’s now moving into the mainstream.
Read MoreWaters and BD are merging BD’s Biosciences & Diagnostic Solutions unit with Waters in a $17.5 billion Reverse Morris Trust transaction.
Read MoreQuanterix Corporation has completed its acquisition of Akoya Biosciences, expanding its capabilities and market reach.
Read MoreLabcorp Whole Health Solutions is a new initiative offering specialized test panels and over 1,000 biomarkers.
Read MorebioMérieux is acquiring the assets of Day Zero Diagnostics to enhance its capabilities in NGS and rapid infectious disease diagnostics.
Read MoreAccess Medical Labs has fully transitioned to Roche Diagnostics equipment in under 30 days, increasing testing speed, capacity & efficiency.
Read MorePictor has launched its U.S. headquarters in California to expand access to its affordable, high-performance multiplex proteomics platform.
Read MoreAccelerate Diagnostics has filed for Chapter 11 bankruptcy and plans to sell its assets through a court-supervised process.
Read MoreSSI Diagnostica Group is acquiring Gulf Coast Scientific to expand its gastrointestinal disease testing capabilities.
Read MoreBruker Corporation announced a majority investment in RECIPE to strengthen its clinical mass spectrometry capabilities.
Read MoreSource BioScience has acquired Cambridge Clinical Laboratories to expand its clinical diagnostics capabilities and enhance testing services.
Read MoreNeoGenomics has acquired Pathline, LLC to strengthen its presence in the Northeast U.S. and accelerate growth in oncology testing services.
Read MoreNeoGenomics, Inc. has acquired Pathliine, expanding its oncology testing services and accelerating growth in other testing.
Read MoreCo-Diagnostics successfully won the complete dismissal of a securities class action lawsuit on March 4, 2025.
Read More